List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 131 studies with search of: "Mesothelioma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
2 Active, not recruiting Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
Conditions: Pleural Mesothelioma;   Malignant Pleural Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Sodium Thiosulfate
3 Recruiting Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Imatinib Mesylate;   Drug: Pemetrexed
4 Completed SU5416 in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: semaxanib
5 Completed Gefitinib in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: gefitinib
6 Active, not recruiting Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: methotrexate;   Drug: vinorelbine ditartrate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
7 Recruiting Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: dasatinib;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
8 Active, not recruiting Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: pazopanib hydrochloride;   Other: laboratory biomarker analysis
9 Active, not recruiting Sorafenib in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: sorafenib tosylate
10 Completed Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: epirubicin hydrochloride;   Drug: gemcitabine hydrochloride
11 Recruiting Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: bortezomib;   Procedure: quality-of-life assessment
12 Active, not recruiting Capecitabine in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: capecitabine
13 Active, not recruiting PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: vatalanib
14 Recruiting Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
Conditions: Malignant Mesothelioma;   Metastatic Cancer
Interventions: Other: talc;   Procedure: therapeutic thoracoscopic surgery;   Procedure: therapeutic thoracoscopy;   Procedure: therapeutic videothoracoscopy
15 Active, not recruiting Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: mitomycin C;   Drug: vinblastine;   Drug: vinorelbine ditartrate
16 Active, not recruiting Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: pemetrexed disodium;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
17 Recruiting Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: bortezomib;   Drug: cisplatin
18 Active, not recruiting Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: mitomycin C;   Drug: vincristine sulfate;   Drug: vinorelbine ditartrate;   Procedure: pain therapy;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
19 Active, not recruiting Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Biological: PA-1-STK ovarian carcinoma vaccine;   Drug: ganciclovir
20 Active, not recruiting Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: liposomal NDDP;   Procedure: thoracoscopic surgery

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services